Verrica Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
VRCA Verrica Pharmaceuticals Inc
ALMMF Aluminum Corp of China Ltd
FUN Cedar Fair LP
BAC Bank of America Corp
XLF Financial Select Sector SPDR® Fund
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
BIIB Biogen Inc
CNF CNFinance Holdings Ltd
LVS Las Vegas Sands Corp
Go

Health Care : Pharmaceuticals |
Company profile

Verrica Pharmaceuticals Inc. is a United States-based clinical-stage medical dermatology company. The Company is focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its lead product candidate, VP-102, is a drug-device combination of topical solution of cantharidin. The Company also intends to develop second cantharidin-based product candidate, VP-103, for the treatment of plantar warts. The Company has completed one Phase II clinical trial of topical solution of cantharidin administered with the wooden stick part of a cotton-tipped swab. It also conducting another Phase II clinical trial of topical solution of cantharidin administered through applicator, which collectively refer to as VP-102, for the treatment of molluscum.

Closing Price
$10.30
Day's Change
0.14 (1.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
10.72
Day's Low
10.07
Volume
(Light)
Volume:
111,091

10-day average volume:
140,059
111,091
  • Prev Close
    10.16
  • Today's Open
    10.41
  • Day's Range
    10.07-10.72
  • Avg Vol (10-day)
    140.1K
  • Last (time)
    4:00p ET 07/02/20
  • Last (size)
    10
  • 52-Wk Range
    6.79 - 18.67
    LowHigh
  • (11/26/19 - 03/12/20)
    51.69%
  • 102.1%
  • Market Cap
    265.9M
  • Shares Outstanding
    25.8M
  • -1.23
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 34.79
  • (% of float 06/15/20)
    5.28

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.